Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis.

J Formos Med Assoc · 2021 · PMC8096194 · PMID 34074579

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally statistically significantno p-value reported

Compared with the empirical results on marginally statistically significant reduction in the risk for death (HR, 0.73; 95% CI, 0.52–1.03) derived from the two-arm RCT of remdesivir, 19 , 20 the point estimate was consistent but our proposed approach was more precise due to the incorporation of information sources derived from both the one-arm study and the two-arm trial.

also in 1,110 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.